首页> 外文期刊>Familial cancer >Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment
【24h】

Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment

机译:Health Heritage的初始临床验证,这是一种面向患者的个人和家族史收集工具以及癌症风险评估工具

获取原文
获取原文并翻译 | 示例
           

摘要

Personal and family health histories remain important independent risk factors for cancer; however they are currently not being well collected or used effectively. Health Heritage was designed to address this need. The purpose of this study was to validate the ability of Health Heritage to identify patients appropriate for further genetic evaluation and to accurately stratify cancer risk. A retrospective chart review was conducted on 100 random patients seen at an adult genetics clinic presenting with concern for an inherited predisposition to cancer. Relevant personal and family history obtained from the patients' medical records was entered into Health Heritage. Recommendations by Health Heritage were compared to national guidelines of eligibility for genetic evaluation. Agreement between Health Heritage referral for genetic evaluation and guideline eligibility for genetic evaluation was 97 % (sensitivity 98 % and specificity 88 %). Risk stratification for cancer was also compared between Health Heritage and those documented by a geneticist. For patients at increased risk for breast, ovarian, or colorectal cancer as determined by the geneticist, risk stratification by Health Heritage agreed 90, 93, and 75 %, respectively. Discordances in risk stratification were attributed to both complex situations better handled by the geneticist and Health Heritage's adherence to incorporating all information into its algorithms. Health Heritage is a clinically valid tool to identify patients appropriate for further genetic evaluation and to encourage them to confirm the assessment and management recommendations with cancer genetic experts. Health Heritage also provides an estimate of cancer risk that is complementary to a genetics team.
机译:个人和家庭健康史仍然是癌症的重要独立危险因素。但是,它们目前没有得到很好的收集或有效利用。健康遗产旨在解决这一需求。这项研究的目的是验证Health Heritage识别适合进一步遗传评估的患者的能力,并准确地将癌症风险分层。回顾性图表审查了在成人遗传学诊所就诊的100位随机患者,这些患者对遗传的遗传易感性表示关注。从患者的病历中获得的相关个人和家族史被输入到Health Heritage中。将《健康遗产》的建议与国家基因评估资格指南进行了比较。 Health Heritage进行遗传评估的转介与遗传评估指南的符合率为97%(敏感性98%和特异性88%)。还比较了健康遗产和遗传学家记录的癌症风险分层。由遗传学家确定,对于患乳腺癌,卵巢癌或结肠直肠癌的风险增加的患者,Health Heritage的风险分层分别为90%,93%和75%。风险分层的不一致性归因于遗传学家更好地处理了两种复杂情况,而且卫生部坚持将所有信息纳入其算法。 Health Heritage是一种临床有效工具,可识别适合进一步遗传评估的患者,并鼓励他们与癌症遗传专家确认评估和治疗建议。 Health Heritage还提供了对癌症风险的估计,作为遗传学团队的补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号